Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GLYCLAZIDE TABLET 80 MG - HSA Drug Approval Details

Approvals/HSA/GLYCLAZIDE TABLET 80 MG

Approved

THERAPEUTIC

GLYCLAZIDE TABLET 80 MG

SAM CHUN DANG PHARM CO LTD (KOREA, REPUBLIC OF)🇸🇬 Health Sciences Authority

Approval Date: Jan 20, 1996
Approval ID: 33504733ef59daa6
Company: SAM CHUN DANG PHARM CO LTD (KOREA, REPUBLIC OF)
Type: Therapeutic

Approval Details

Approval Id: 33504733ef59daa6
Drug Name: GLYCLAZIDE TABLET 80 MG
Product Name: GLYCLAZIDE TABLET 80 MG
Approval Number: SIN08529P
Approval Date: 1996-01-20
Registrant: ZYFAS PHARMA PTE LTD
Licence Holder: ZYFAS PHARMA PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: A10BB09
Atc Item Name: gliclazide
Pharma Manufacturer Name: ZYFAS PHARMA PTE. LTD.
Company Detail Path: /organization/zyfas-pharma-pte-ltd

Active Ingredients

GLICLAZIDE

80 mg

GLICLAZIDE

80 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 20, 1996

Approval ID

33504733ef59daa6

Type

Therapeutic

Back to HSA Approvals